2015
DOI: 10.3109/21681805.2015.1004642
|View full text |Cite
|
Sign up to set email alerts
|

Differentiated adipose-derived stem cells for bladder bioengineering

Abstract: Objective. The aim of this study was to characterize and differentiate adipose-derived stem cells (ADSCs) to functional smooth muscle cells (SMCs) as an alternative cell source for bladder engineering. Materials and methods. Rat ADSCs were differentiated into SMCs for 1-6 weeks using induction medium. The changes in contractile genes and protein expression were investigated by real-time polymerase chain reaction, fluorescence-activated cell sorting and Western blot at different time-points. Spontaneous and car… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
20
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 15 publications
(21 citation statements)
references
References 31 publications
1
20
0
Order By: Relevance
“…Therefore, hADSCs have become an attractive stem cell source for tissue engineering. Many researchers have investigated the smooth muscle differentiation of hADSCs due to their promising applications in the field of cellular therapies involving urinary and cardiovascular systems (Choi et al, 2010; Fu et al, 2010; Salemi et al, 2015). These studies provided various methods for smooth muscle cell differentiation, including co-culturing hADSCs with primary myoblasts using heparin, 5-azacytidine or transforming growth factor β1 (TGF-β1) as smooth muscle inducing factors and attaching hADSCs to microcarriers created by thermally induced phase separation (TIPS; Di Rocco et al, 2006; Rodriguez et al, 2006; Meligy et al, 2012; Park et al, 2013; Parmar et al, 2015).…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, hADSCs have become an attractive stem cell source for tissue engineering. Many researchers have investigated the smooth muscle differentiation of hADSCs due to their promising applications in the field of cellular therapies involving urinary and cardiovascular systems (Choi et al, 2010; Fu et al, 2010; Salemi et al, 2015). These studies provided various methods for smooth muscle cell differentiation, including co-culturing hADSCs with primary myoblasts using heparin, 5-azacytidine or transforming growth factor β1 (TGF-β1) as smooth muscle inducing factors and attaching hADSCs to microcarriers created by thermally induced phase separation (TIPS; Di Rocco et al, 2006; Rodriguez et al, 2006; Meligy et al, 2012; Park et al, 2013; Parmar et al, 2015).…”
Section: Introductionmentioning
confidence: 99%
“…For negative controls, the primary antibody was omitted. The specificity of the commercial antibodies has been thoroughly validated in our former studies …”
Section: Methodsmentioning
confidence: 99%
“…The specificity of the commercial antibodies has been thoroughly validated in our former studies. 19,20 2.6 | Pharmacological modulation of autophagy Biopsy-derived SMCs were cultured in the presence of 2 mM and 10 mM 3-methyladenine (3-MA) (Sigma-Aldrich, Buchs, Switzerland), a pharmacological inhibitor commonly used to block autophagy. 21 Treatment of the cells with 2 mM 3-MA was performed under culture conditions after 7 days and the treatment with 10 mM 3-MA was for 24 h only.…”
Section: Immunofluorescent Stainingmentioning
confidence: 99%
“…Recently, stem cells derived from urine or adipose tissue have been successfully differentiated to functional smooth muscle cells for bladder tissue engineering applications. In addition, these stem cells can be harvested from the patient relatively easy, providing an autologous cell source [ 25 , 26 ].…”
Section: Discussionmentioning
confidence: 99%